SUBSEQUENT EVENTS	9 Months Ended
May 31, 2026
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14 – SUBSEQUENT EVENTS Management has evaluated subsequent events through the date these financial statements were issued. On June 12, 2026, the Company entered into an exclusive License and Research Collaboration Agreement with The University of Edinburgh, acting through Edinburgh Innovations Limited. The agreement grants the Company an exclusive worldwide license to develop, commercialize, and sublicense certain proprietary marketing analytics technologies and intellectual property within the fields of marketing mix modeling, attribution analytics, predictive consumer behavior analytics, and related software solutions. The agreement also provides for future research funding, royalty obligations, and certain equity participation rights upon the occurrence of specified financing events. The agreement requires a non-refundable initial license fee of $30,000 and provides for a three-year sponsored research program beginning September 1, 2026 at an annual funding commitment of $180,000. The agreement also includes revenue-based royalty and sublicensing obligations and contingent equity participation rights. The Company believes this agreement represents a significant milestone in its commercialization strategy and future product development initiatives. Additionally, effective July 2, 2026, the Company appointed Scott David Miller as Product & Analytics Lead, and effective July 3, 2026, appointed Thomas Bennett as Data Science / Modeling Lead. Management believes these appointments strengthen the Company's technical capabilities and support the continued commercialization and expansion of the MMM Neural platform. Subsequent to May 31, 2026, and through the date of these financial statements, the Company issued an additional 2,650,000 shares of its common stock to various investors for cash in connection with its ongoing offering. Following these issuances, the Company had 8,275,000 shares issued and outstanding. Except as disclosed above, management is not aware of any material subsequent events requiring adjustment to or disclosure in these financial statements.

SUBSEQUENT EVENTS

9 Months Ended

May 31, 2026

NOTE 14 – SUBSEQUENT EVENTS

Management has evaluated subsequent events through the date these financial statements were issued.

On June 12, 2026, the Company entered into an exclusive License and Research Collaboration Agreement with The University of Edinburgh, acting through Edinburgh Innovations Limited. The agreement grants the Company an exclusive worldwide license to develop, commercialize, and sublicense certain proprietary marketing analytics technologies and intellectual property within the fields of marketing mix modeling, attribution analytics, predictive consumer behavior analytics, and related software solutions. The agreement also provides for future research funding, royalty obligations, and certain equity participation rights upon the occurrence of specified financing events.

The agreement requires a non-refundable initial license fee of $30,000 and provides for a three-year sponsored research program beginning September 1, 2026 at an annual funding commitment of $180,000. The agreement also includes revenue-based royalty and sublicensing obligations and contingent equity participation rights.

The Company believes this agreement represents a significant milestone in its commercialization strategy and future product development initiatives.

Additionally, effective July 2, 2026, the Company appointed Scott David Miller as Product & Analytics Lead, and effective July 3, 2026, appointed Thomas Bennett as Data Science / Modeling Lead. Management believes these appointments strengthen the Company's technical capabilities and support the continued commercialization and expansion of the MMM Neural platform.

Subsequent to May 31, 2026, and through the date of these financial statements, the Company issued an additional 2,650,000 shares of its common stock to various investors for cash in connection with its ongoing offering. Following these issuances, the Company had 8,275,000 shares issued and outstanding.

Except as disclosed above, management is not aware of any material subsequent events requiring adjustment to or disclosure in these financial statements.